313 results on '"Lodi S"'
Search Results
102. Deficiencies of the normal moment yield criterion for RC slabs
- Author
-
May, I. M., primary and Lodi, S. H., additional
- Published
- 2005
- Full Text
- View/download PDF
103. W*-Grid: A Robust Decentralized Cross-layer Infrastructure for Routing and Multi-Dimensional Data Management in Wireless Ad-Hoc Sensor Networks.
- Author
-
Monti, G., Moro, G., and Lodi, S.
- Published
- 2007
- Full Text
- View/download PDF
104. Inferences on Kernel Density Estimates by Solving Nonlinear Systems.
- Author
-
Bellavia, S., Lodi, S., and Morini, B.
- Published
- 2006
- Full Text
- View/download PDF
105. The role of agents in distributed data mining: issues and benefits.
- Author
-
Klusch, M., Lodi, S., and Gianluca, M.
- Published
- 2003
- Full Text
- View/download PDF
106. The behaviour of reinforced concrete elements subject to bending and twisting moments
- Author
-
May, I. M., primary, Montague, P., additional, Samad, A. A. A., additional, Lodi, S. H., additional, and Fraser, A. S., additional
- Published
- 2001
- Full Text
- View/download PDF
107. Detecting outbreaks by time series analysis.
- Author
-
Cellarosi, G., Lodi, S., and Sartori, C.
- Published
- 2002
- Full Text
- View/download PDF
108. Connections between parameters of GRB afterglows.
- Author
-
Beskin, G. M., Bartolini, C., Cosentino, G., Guarnieri, A., Lodi, S., and Piccioni, A.
- Subjects
AFTERGLOW (Physics) ,GAMMA ray bursts - Abstract
The optical light curves of GRBs can be grouped in two families according to their α values. Significant clues to investigate the physics of GRBs could come from the detection of correlations between the parameters of optically identified GRB afterglows. © 2000 American Institute of Physics. [ABSTRACT FROM AUTHOR]
- Published
- 2000
109. Consistency checking in complex object database schemata with integrity constraints
- Author
-
Beneventano, D., primary, Bergamaschi, S., additional, Lodi, S., additional, and Sartori, C., additional
- Published
- 1998
- Full Text
- View/download PDF
110. Consistency Checking in Complex Object Database Schemata with Integrity Constraints
- Author
-
Beneventano, D., primary, Bergamaschi, S, additional, Lodi, S, additional, and Sartori, C., additional
- Published
- 1995
- Full Text
- View/download PDF
111. Determination of some organic acids in sugar factory products
- Author
-
Lodi, S., primary and Rossin, G., additional
- Published
- 1995
- Full Text
- View/download PDF
112. Direct Enzyme-Immunoassay for Plasma Androstenedione
- Author
-
Preti, M. S., primary, Magrini, O., additional, Lodi, S., additional, Melega, C., additional, Paradisi, R., additional, and Flamigni, C., additional
- Published
- 1991
- Full Text
- View/download PDF
113. The behaviour of reinforced concrete elements subject to bending and twisting moments.
- Author
-
Fraser, A. S., May, I. M., Lodi, S. H., Montague, P., and Samad, A. A. A.
- Published
- 2001
- Full Text
- View/download PDF
114. Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability
- Author
-
Magnani, M, Stocchi, V, Cucchiarini, L, Novelli, G, Lodi, S, Isa, L, and Fornaini, G
- Abstract
A 27-year-old woman with severe chronic hemolytic anemia was found to have reduced red cell hexokinase activity when the degree of reticulocytosis was considered. This enzyme had normal pH-dependent activity, normal Km for glucose, fructose, and mannose, normal Km for Mg adenosine triphosphate (ATP)2- and Ki for glucose-1,6-diphosphate. Furthermore, the pH-dependence and orthophosphate dependence of Ki for glucose-1,6-diphosphate were normal. However, this hexokinase was inactivated rapidly at 44 degrees C. No abnormalities were found in the red cell hexokinase isozymic pattern when it was compared with the profile obtained from cells of similar age. The hexokinase specific activity was reduced in all the red blood cell fractions obtained by density gradient ultracentrifugation; a marked difference in the distribution of cells through the gradient was evident. Among the glycolytic intermediates, a significant decrease of 2,3- diphosphoglycerate was evident. ATP and glucose 6-phosphate were also reduced when compared with cells of similar. Glucose consumption of the hexokinase-deficient cells decreased, but the rate of glucose metabolized through the hexose monophosphate shunt was unchanged. Although the total hexokinase activity in lymphocytes was only reduced by 37%, a marked hexokinase deficiency was detected in blood platelets (20% to 25% of normal activity). The parents and one of two siblings of the patient were heterozygous for the defect, with 66% to 74% of normal erythrocyte hexokinase activity and reduced heat stability of the enzyme. These results, when compared with those obtained in previously reported cases of hexokinase deficiency, provide further evidence of the broad phenotypic variability that characterizes this disorder. Furthermore, it is suggested that failure of energy generation is probably the primary cause of hemolytic anemia in hexokinase deficiency.
- Published
- 1985
- Full Text
- View/download PDF
115. Entita'-Situazione: un modello di rappresentazione della conoscenza
- Author
-
Bergamaschi, Sonia, Lodi, S., and Sartori, C.
- Subjects
modelli concettuali ,rappresentazione della conoscenza - Published
- 1989
116. Un editor intelligente per la costruzione di una base di conoscenza secondo il modello entita' situazione
- Author
-
Bergamaschi, Sonia, Lodi, S., and Sartori, C.
- Subjects
modellazione concettuale - Published
- 1989
117. Inference attacks in peer-to-peer homogeneous distributed data mining
- Author
-
Da Silva, J. C., Klusch, M., Lodi, S., Gianluca Moro, R. LÓPEZ DE MÁNTARAS, L. SAITTA, J. Costa da Silva, M. Klusch, S. Lodi, and G. Moro
- Abstract
Spontaneous formation of peer-to-peer agent-based data mining systems seems a plausible scenario in years to come. However, the emergence of peer-to-peer environments further exacerbates privacy and security concerns that arise when performing data mining tasks. We analyze potential threats to data privacy in a peer-to-peer agent-based distributed data mining scenario, and discuss inference attacks which could compromise data privacy in a peer-to-peer distributed clustering scheme known as KDEC.
118. Boosting a network of semantic peers (extended abstract)
- Author
-
Lodi, S., Federica Mandreoli, Martoglia, R., Penzo, W., and Sassatelli, S.
119. An integrated data mining and data presentation tool
- Author
-
Fabrizio Angiulli, Catarci, T., Ciaccia, P., Ianni, G., Kimani, S., Lodi, S., Patella, M., Santucci, G., and Sartori, C.
120. When to initiate combined antiretroviral therapy to reduce mortality and aids-defining illness in HIV-infected persons in developed countries
- Author
-
Cain, L. E., Logan, R., Robins, J. M., Hernán, M. A., Sterne, J. A. C., Sabin, C., Bansi, L., Goulet, J., Justice, A., Sighem, A., Wolf, F., Bucher, H. C., Wyl, V., Esteve, A., Casabona, J., Del Amo, J., Moreno, S., Seng, R., Meyer, L., Santiago Pérez-Hoyos, Muga, R., Lodi, S., Lanoy, E., and Costagliola, D.
121. Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples
- Author
-
Phillips, A., Sterne, J.A.C., Law, M., Touloumi, G., Babiker, A., Horban, A., Porter, K., Meyer, L., Jarrin, I., Perez-Hoyos, S., Sharma, S., Chu, H., Lodi, S., Logan, R., Cole, S.R., Gill, J., Hernán, M.A., Wittkop, L., Lundgren, J., Reiss, P., Costagliola, D., Justice, A., Sabin, C., Pacheco, A.G., Neaton, J.D., Van Sighem, A., Bucher, H.C., Montoliu Giménez, A., Abgrall, S., and Byrne, D.
- Subjects
3. Good health - Abstract
Effect estimates from randomized trials and observational studies might not be directly comparable because of differences in study design, other than randomization, and in data analysis. We propose a 3-step procedure to facilitate meaningful comparisons of effect estimates from randomized trials and observational studies: 1) harmonization of the study protocols (eligibility criteria, treatment strategies, outcome, start and end of follow-up, causal contrast) so that the studies target the same causal effect, 2) harmonization of the data analysis to estimate the causal effect, and 3) sensitivity analyses to investigate the impact of discrepancies that could not be accounted for in the harmonization process. To illustrate our approach, we compared estimates of the effect of immediate with deferred initiation of antiretroviral therapy in individuals positive for the human immunodeficiency virus from the Strategic Timing of Antiretroviral Therapy (START) randomized trial and the observational HIV-CAUSAL Collaboration.
122. Non-pharmacological treatment for chronic obstructive pulmonary disease
- Author
-
Clini, E., Stefania Costi, Lodi, S., and Rossi, G.
123. Stream clustering based on kernel density estimation
- Author
-
Lodi, S., Moro, G., Claudio Sartori, G. BREWKA, S. CORADESCHI, A. PERINI, P. TRAVERSO, S. Lodi, G. Moro, and C. Sartori
- Subjects
DATA CLUSTERING ,DATA STREAM ,KERNEL DENSITY ESTIMATE - Abstract
We present a novel algorithm for clustering streams of multidimensional points based on kernel density estimates of the data. The algorithm requires only one pass over each data point and a constant amount of space, which depends only on the accuracy of clustering. The algorithm recognizes clusters of nonspherical shapes and handles both inserted and deleted objects in the input stream. Querying the membership of a point in a cluster can be answered in constant time.
124. Mental disorders and criminal behavior: A genetic approach
- Author
-
Verga, M., Pedrini, S., alessandro serretti, Macciardi, F., Lodi, S., and Mencacci, C.
125. Distributed data clustering in multi-dimensional peer-to-peer networks
- Author
-
Lodi, S., Gianluca Moro, Sartori, C., Stefano Lodi, Gianluca Moro, and Claudio Sartori
- Subjects
DATA CLUSTERING ,MULTI-DIMENSIONAL DATA ,DISTRIBUTED SYSTEMS ,PEER-TO-PEER NETWORKS - Abstract
Several algorithms have been recently developed for distributed data clustering, which are applied when data cannot be concentrated on a single machine, for instance because of privacy reasons or due to net- work bandwidth limitations, or because of the huge amount of distributed data. Deployed and research Peer-to-Peer systems have proven to be able to man- age very large databases made up by thousands of personal computers resulting in a concrete solutions for the forthcoming new distributed database systems to be used in large grid computing networks and in clustering database management systems. Current distributed data clustering algorithms cannot be ap- plied to such kind of networks because they expect data be organized according to traditional distributed database management systems where the distribution of the relational schema is planned a-priori in the de- sign phase. In this paper we describe methods to cluster distributed data across peer-to-peer networks without requiring any costly reorganization of data, which would be infeasible in such a large and dynamic overlay networks, and without reducing their perfor- mance in message routing and query processing. We compare the data clustering quality and ef- ciency of three multi-dimensional peer-to-peer sys- tems according to two well-known clustering tech- niques.
126. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
- Author
-
Lodi, S, Sharma, S, Lundgren, JD, Phillips, AN, Cole, SR, Logan, R, Agan, BK, Babiker, A, Klinker, H, Chu, H, Law, M, Neaton, JD, Hernán, MA, INSIGHT Strategic Timing of AntiRetroviral Treatment (START) study group, Lodi, S, Sharma, S, Lundgren, JD, Phillips, AN, Cole, SR, Logan, R, Agan, BK, Babiker, A, Klinker, H, Chu, H, Law, M, Neaton, JD, Hernán, MA, and INSIGHT Strategic Timing of AntiRetroviral Treatment (START) study group
- Abstract
OBJECTIVE: The Strategic Timing of AntiRetroviral Treatment (START) trial found a lower risk of a composite clinical outcome in HIV-positive individuals assigned to immediate initiation of antiretroviral therapy (ART) compared with those assigned to deferred initiation. However, 30% of those assigned to deferred initiation started ART earlier than the protocol specified. To supplement the published intention-to-treat (ITT) effect estimates, here we estimate the per-protocol effect of immediate versus deferred ART initiation in START. DESIGN: The START trial randomized 4685 HIV-positive participants with CD4 cell counts more than 500 cells/μl to start ART immediately after randomization (immediate initiation group) or to wait until the CD4 cell count dropped below 350 cells/μl or an AIDS diagnosis (deferred initiation group). METHODS: We used the parametric g-formula to estimate and compare the cumulative 5-year risk of the composite clinical outcome in the immediate initiation group, and deferred initiation groups had all the trial participants adhered to the protocol. RESULTS: We estimated that the 5-year risk of the composite outcome would have been 3.2% under immediate ART initiation and 7.0% under deferred initiation. The difference of 3.8% (95% confidence interval 1.5, 6.5) was larger than the ITT effect estimate of 3.1%, corresponding to a difference in effect estimates of 0.72% (-0.35, 2.35). CONCLUSION: The ITT effect estimate may underestimate the benefit of immediate ART initiation by 23%. This estimate can be used by patients and policy-makers who need to understand the full extent of the benefit of changes in ART initiation policies.
127. Heroin addiction: Relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin
- Author
-
Bolelli, G., primary, Lafisca, S., additional, Flamnigni, C., additional, Lodi, S., additional, Franceschetti, F., additional, Filicori, M., additional, and Mosca, R., additional
- Published
- 1979
- Full Text
- View/download PDF
128. Androstenedione metabolism in human uterine tissues: Endometrium, myometrium and leiomyoma
- Author
-
Jasonni, V.M., primary, Bonavia, M., additional, Lodi, S., additional, Preti, S., additional, Bulletti, C., additional, and Flamigni, C., additional
- Published
- 1982
- Full Text
- View/download PDF
129. Development of a sensitive enzyme immunoassay for plasma and salivary steroids
- Author
-
Roda, A., primary, Girotti, S., additional, Lodi, S., additional, and Preti, S., additional
- Published
- 1984
- Full Text
- View/download PDF
130. Development of a sensitive, direct luminescent enzyme immunoassay for plasma estradiol-17β
- Author
-
Roda, A., primary, Girotti, S., additional, Piacentini, A.L., additional, Preti, S., additional, and Lodi, S., additional
- Published
- 1986
- Full Text
- View/download PDF
131. Recurrent Intra-Uterine Deaths, Venous Thrombosis and “Lupus Anticoagulant”
- Author
-
Isa, L., primary and Lodi, S., additional
- Published
- 1985
- Full Text
- View/download PDF
132. Elisa for salivary and plasma estriol in pregnancy
- Author
-
Preti, M.S., primary, Lodi, S., additional, Busacchi, P., additional, Filicori, M., additional, and Flamigni, C., additional
- Published
- 1984
- Full Text
- View/download PDF
133. The role of agents in distributed data mining: issues and benefits
- Author
-
Klusch, M., primary, Lodi, S., additional, and Gianluca, M., additional
- Full Text
- View/download PDF
134. Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome
- Author
-
Egger Peter, Carpenter James, Lodi Sara, and Evans Stephen
- Subjects
Medicine (General) ,R5-920 - Abstract
Abstract Background There has been little research on design of studies based on routinely collected data when the clinical endpoint of interest is not recorded, but can be inferred from a prescription. This often happens when exploring the effect of a drug on chronic diseases. Using the LifeLink claims database in studying the possible anti-inflammatory effects of statins in rheumatoid arthritis (RA), oral steroids (OS) were treated as surrogate of inflammatory flare-ups. We compared two cohort study designs, the first using time to event outcomes and the second using quantitative amount of the surrogate. Methods RA patients were extracted from the LifeLink database. In the first study, patients were split into two sub-cohorts based on whether they were using OS within a specified time window of the RA index date (first record of RA). Using Cox models we evaluated the association between time-varying exposure to statins and (i) initiation of OS therapy in the non-users of OS at RA index date and (ii) cessation of OS therapy in the users of OS at RA index date. In the second study, we matched new statin users to non users on age and sex. Zero inflated negative binomial models were used to contrast the number of days' prescriptions of OS in the year following date of statin initiation for the two exposure groups. Results In the unmatched study, the statin exposure hazard ratio (HR) of initiating OS in the 31451 non-users of OS at RA index date was 0.96(95% CI 0.9,1.1) and the statin exposure HR of cessation of OS therapy in the 6026 users of OS therapy at RA index date was 0.95 (0.87,1.05). In the matched cohort of 6288 RA patients the statin exposure rate ratio for duration on OS therapy was 0.88(0.76,1.02). There was digit preference for outcomes in multiples of 7 and 30 days. Conclusions The 'time to event' study design was preferable because it better exploits information on all available patients and provides a degree of robustness toward confounding. We found no convincing evidence that statins reduce inflammation in RA patients.
- Published
- 2011
- Full Text
- View/download PDF
135. O114. Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection.
- Author
-
Lodi, S., Kücherer, C., Kran, A. M. Bakken, Masquelier, B., Monforte, A. d'Arminio, Gill, J., Dunn, D., Pillay, D., and Porter, K.
- Subjects
- *
HIV-positive persons , *ANTIVIRAL agents - Abstract
An abstract of the research paper "Long-Term Probability of Detecting Drug-Resistant HIV in Patients Starting Antiretroviral Therapy Within the First Year of HIV infection," by S. Lodi and colleagues which was presented at the Tenth International Congress on Drug Therapy in HIV Infection held at Glasgow, Scotland from November 7-11, 2010 is presented.
- Published
- 2010
- Full Text
- View/download PDF
136. Shear Behavior of Ferrocement Thin Webbed Sections
- Author
-
Ahmad, S. F., Lodi, S. H., and Qureshi, J.
- Published
- 1995
- Full Text
- View/download PDF
137. The E/S knowledge representation system
- Author
-
Bergamaschi, S., Lodi, S., and Sartori, C.
- Published
- 1994
- Full Text
- View/download PDF
138. The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy
- Author
-
Carlo Casablanca, Francesco Chessa, Michelangelo Fiorentino, Stefano Diciotti, Daniele Romagnoli, Simone Lodi, Riccardo Schiavina, A. Mottaran, Alexandre Mottrie, Stefano Puliatti, Caterina Gaudiano, Lorenzo Bianchi, Angelo Porreca, Matteo Droghetti, E. Molinaroli, Andrea Angiolini, Pietro Piazza, Emanuela Marcelli, Francesca Giunchi, Rita Golfieri, Laura Cercenelli, Barbara Bortolani, Bianchi L., Chessa F., Angiolini A., Cercenelli L., Lodi S., Bortolani B., Molinaroli E., Casablanca C., Droghetti M., Gaudiano C., Mottaran A., Porreca A., Golfieri R., Romagnoli D., Giunchi F., Fiorentino M., Piazza P., Puliatti S., Diciotti S., Marcelli E., Mottrie A., and Schiavina R.
- Subjects
medicine.medical_specialty ,Surgical margin ,Intraoperative frozen section ,Prostate cancer ,Index Lesion ,Prostatectomy ,business.industry ,Urology ,medicine.medical_treatment ,Augmented reality ,Three-dimensional reconstruction ,medicine.disease ,Dissection ,Propensity score matching ,Robot-assisted radical prostatectomy ,medicine ,Radiology ,Positive Surgical Margin ,Stage (cooking) ,business - Abstract
Background Multiparametric magnetic resonance imaging (mpMRI) can guide the surgical plan during robot-assisted radical prostatectomy (RARP), and intraoperative frozen section (IFS) can facilitate real-time surgical margin assessment. Objective To assess a novel technique of IFS targeted to the index lesion by using augmented reality three-dimensional (AR-3D) models in patients scheduled for nerve-sparing RARP (NS-RARP). Design, setting, and participants Between March 2019 and July 2019, 20 consecutive prostate cancer patients underwent NS-RARP with IFS directed to the index lesion with the help of AR-3D models (study group). Control group consists of 20 patients matched with 1:1 propensity score for age, clinical stage, Prostate Imaging Reporting and Data System score v2, International Society of Urological Pathology grade, prostate volume, NS approach, and prostate-specific antigen in which RARP was performed by cognitive assessment of mpMRI. Surgical procedure In the study group, an AR-3D model was superimposed to the surgical field to guide the surgical dissection. Tissue sampling for IFS was taken in the area in which the index lesion was projected by AR-3D guidance. Measurements Chi-square test, Student t test, and Mann-Whitney U test were used to compare, respectively, proportions, means, and medians between the two groups. Results and limitations Patients in the AR-3D group had comparable preoperative characteristics and those undergoing the NS approach were referred to as the control group (all p ≥ 0.06). Overall, positive surgical margin (PSM) rates were comparable between the two groups; PSMs at the level of the index lesion were significantly lower in patients referred to AR-3D guided IFS to the index lesion (5%) than those in the control group (20%; p = 0.01). Conclusions The novel technique of AR-3D guidance for IFS analysis may allow for reducing PSMs at the level of the index lesion. Patient summary Augmented reality three-dimensional guidance for intraoperative frozen section analysis during robot-assisted radical prostatectomy facilitates the real-time assessment of surgical margins and may reduce positive surgical margins at the index lesion.
- Published
- 2021
139. The Impact of 3D Digital Reconstruction on the Surgical Planning of Partial Nephrectomy: A Case-control Study. Still Time for a Novel Surgical Trend?
- Author
-
Lorenzo Bianchi, Simone Lodi, Carlo Casablanca, Caterina Gaudiano, A. Ercolino, Alessandro Bertaccini, Emanuela Marcelli, Riccardo Schiavina, Rita Golfieri, Francesco Chessa, Laura Cercenelli, Andrea Angiolini, U. Barbaresi, Barbara Bortolani, Angelo Porreca, Federico Mineo Bianchi, Bianchi L., Barbaresi U., Cercenelli L., Bortolani B., Gaudiano C., Chessa F., Angiolini A., Lodi S., Porreca A., Bianchi F.M., Casablanca C., Ercolino A., Bertaccini A., Golfieri R., Marcelli E., and Schiavina R.
- Subjects
3D model ,medicine.medical_specialty ,Digital reconstruction ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,3d model ,Kidney ,Nephrectomy ,Surgical planning ,03 medical and health sciences ,Imaging, Three-Dimensional ,0302 clinical medicine ,medicine ,Renal mass ,Partial nephrectomy ,Humans ,Preoperative planning ,business.industry ,Case-control study ,Surgical outcomes ,Kidney Neoplasms ,Surgery ,Renal cancer ,Oncology ,Case-Control Studies ,030220 oncology & carcinogenesis ,Intraoperative management ,Selective clamping ,business - Abstract
Introduction The purpose of this study was to evaluate the impact of 3-dimensional (3D) digital reconstructions of renal models on the arterial clamping approach during partial nephrectomy (PN). Patients and Methods Fifty-seven patients with T1 renal mass, referred for PN, were prospectively enrolled in 2 groups: Group 1 (n = 32) with revision of both 2-dimensional (2D) computed tomography (CT) imaging and 3D virtual model before surgery; Group 2 (n = 25) with revision of 2D CT imaging. Segmentation of the 3D models from preoperative high-quality CT scan was achieved using D2P software. In a sub-analysis of patients treated with PN with the on-clamp approach (n = 36), the effective intraoperative level of arterial clamping was compared with the preoperative planning. Results In the sub-group of patients referred to PN with the on-clamp approach, the intraoperative selective clamping was performed in 12 (57.1%) patients of Group 1 and in 2 (13.3%) cases of Group 2 (P = .01). The intraoperative management of the renal pedicle was done as preoperatively planned in 61.9% of patients in Group 1 and in 86.6% of cases in Group 2 (P = .1). Conclusion The 3D-guided plan of PN allows to perform selective clamping in higher proportion of patients compared with the standard 2D-guided approach without increasing intraoperative and postoperative complications.
- Published
- 2020
140. Augmented Reality to Guide Selective Clamping and Tumor Dissection During Robot-assisted Partial Nephrectomy: A Preliminary Experience
- Author
-
Carlo Casablanca, Andrea Angiolini, Francesco Chessa, Eugenio Brunocilla, Simone Lodi, U. Barbaresi, E. Molinaroli, Caterina Gaudiano, Stefano Diciotti, Emanuela Marcelli, Barbara Bortolani, A. Ercolino, Riccardo Schiavina, Rita Golfieri, Laura Cercenelli, Lorenzo Bianchi, Federico Mineo Bianchi, Angelo Porreca, Schiavina R., Bianchi L., Chessa F., Barbaresi U., Cercenelli L., Lodi S., Gaudiano C., Bortolani B., Angiolini A., Bianchi F.M., Ercolino A., Casablanca C., Molinaroli E., Porreca A., Golfieri R., Diciotti S., Marcelli E., and Brunocilla E.
- Subjects
3D model ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,3d model ,Augmented reality ,03 medical and health sciences ,0302 clinical medicine ,Robotic partial nephrectomy ,Renal mass ,Medicine ,Surgical approach ,business.industry ,Clamping ,Nephrectomy ,Surgery ,Dissection ,medicine.anatomical_structure ,Renal cancer ,Oncology ,030220 oncology & carcinogenesis ,business ,Selective clamping ,Preoperative imaging ,Artery - Abstract
Introduction to explore the feasibility of augmented reality (AR) to guide arterial clamping during robot-assisted partial nephrectomy (RAPN). Patients and Methods 15 consecutive patients with T1 renal mass underwent RAPN guided by AR. The 3D virtual model derived by computed tomography was superimposed on the actual view provided by the Da Vinci video stream thought AR technology. Preoperative plan of arterial clamping based on 2D conventional imaging, on 3D model and the effective intraoperative surgical approach guided by AR were compared using the McNeamar test. Results The plan of arterial clamping based on 2D preoperative imaging was recorded as follows: no clamping in 3 (20%), clamping of the main artery in 10 (66.7%) and selective clamping in 1 (6.7%) and super-selective clamping in 1 (6.7%) cases. After revision of the 3D model, the plan of clamping was modified as follows: no clamping in 1 (6.7%), clamping of the main artery in 2 (13.3%), selective clamping in 8 (53.3%) and super-selective clamping in 4 (26.7%) cases (p=0.03). The effective intraoperative clamping approach guided by AR-guidance was performed as planned in 13 (86.7%) patients. Conclusion AR for 3D guided renal surgery is useful to increase the adoption of selective clamping during RAPN.
- Published
- 2021
141. Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning
- Author
-
Carlo Casablanca, Eugenio Brunocilla, Daniele Romagnoli, Simone Lodi, Caterina Gaudiano, Emanuela Marcelli, Riccardo Schiavina, Lorenzo Bianchi, Matteo Droghetti, Rita Golfieri, Laura Cercenelli, Stefano Diciotti, Francesca Giunchi, Michelangelo Fiorentino, Barbara Bortolani, Angelo Porreca, Francesco Chessa, Schiavina R., Bianchi L., Lodi S., Cercenelli L., Chessa F., Bortolani B., Gaudiano C., Casablanca C., Droghetti M., Porreca A., Romagnoli D., Golfieri R., Giunchi F., Fiorentino M., Marcelli E., Diciotti S., and Brunocilla E.
- Subjects
Male ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,Three-dimensional reconstruction ,Surgical planning ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Robotic Surgical Procedures ,medicine ,Humans ,Prostatectomy ,Real-time guided surgery ,Augmented Reality ,Index Lesion ,business.industry ,Prostate ,Prostatic Neoplasms ,Robotics ,medicine.disease ,Dissection ,Index lesion ,030220 oncology & carcinogenesis ,Personal computer ,Robot assisted radical prostatectomy ,Augmented reality ,Radiology ,Positive Surgical Margin ,business - Abstract
Background: Augmented reality (AR) is a novel technology adopted in prostatic surgery. Objective: To evaluate the impact of a 3D model with AR (AR-3D model), to guide nerve sparing (NS) during robot-assisted radical prostatectomy (RARP), on surgical planning. Design, Setting, and Participants: Twenty-six consecutive patients with diagnosis of prostate cancer (PCa) and multiparametric magnetic resonance imaging (mpMRI) results available were scheduled for AR-3D NS RARP. Intervention: Segmentation of mpMRI and creation of 3D virtual models were achieved. To develop AR guidance, the surgical DaVinci video stream was sent to an AR-dedicated personal computer, and the 3D virtual model was superimposed and manipulated in real time on the robotic console. Outcome measurements and statistical analysis: The concordance of localisation of the index lesion between the 3D model and the pathological specimen was evaluated using a prostate map of 32 specific areas. A preliminary surgical plan to determinate the extent of the NS approach was recorded based on mpMRI. The final surgical plan was reassessed during surgery by implementation of the AR-3D model guidance. Results and limitations: The positive surgical margin (PSM) rate was 15.4% in the overall patient population; three patients (11.5%) had PSMs at the level of the index lesion. AR-3D technology changed the NS surgical plan in 38.5% of men on patient-based and in 34.6% of sides on side-based analysis, resulting in overall appropriateness of 94.4%. The 3D model revealed 70%, 100%, and 92% of sensitivity, specificity, and accuracy, respectively, at the 32-area map analysis. Conclusions: AR-3D guided surgery is useful for improving the real-time identification of the index lesion and allows changing of the NS approach in approximately one out of three cases, with overall appropriateness of 94.4%. Patient summary: Augmented reality three-dimensional guided robot-assisted radical prostatectomy allows identification of the index prostate cancer during surgery, to tailor the surgical dissection to the index lesion and to change the extent of nerve-sparing dissection. Augmented reality three-dimensional (3D) guided robotic prostatectomy is feasible to improve the real-time identification of index prostate cancer and to modulate the nerve-sparing approach targeted to the index lesion. Augmented reality 3D models revealed good concordance with the whole-mount pathology.
- Published
- 2020
142. Aflatoxin M1 in milk: Reliability of the immunoenzymatic assay
- Author
-
Rosi, P., Borsari, A., Lasi, G., Lodi, S., Galanti, A., Fava, A., Girotti, S., and Ferri, E.
- Subjects
- *
ENZYME-linked immunosorbent assay , *AFLATOXINS , *EXTRACTION (Chemistry) , *MILK - Abstract
Abstract: To evaluate the reliability of ELISA in aflatoxin M1 (AFM1) determination in milk, more than 15,000 samples were tested and results from 600 of them were compared with those of the HPLC reference method. Extraction efficiency by immunoaffinity columns was checked under various conditions. ELISA and HPLC assays of spiked samples gave same precision (coefficient of variation), recovery, and regression coefficient R 2 values (0.9–8%, 96.8–108%, 0.993, respectively) for samples containing less than 70ngL−1 of AFM1. At higher concentrations up to 100ngL−1, ELISA gave a slight overestimation, with CV 7–21% and R 2=0.876. This overestimation was confirmed (R 2=0.788) for the 600 comparison samples. Data from this study support ELISA as a reliable routine quality control assay for AFM1 in milk, quantifying exactly its content for values above, but close to, the legal limit. Regulatory rules require HPLC confirmation of positive samples, but by using ELISA, no cases of false-negative determination should occur. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
143. EVAR-eaSE: An Easy-to-Use Software for Planning Sac Embolization in EndoVascular Aneurysm Repair Procedure
- Author
-
Barbara Bortolani, Simone Lodi, Mauro Gargiulo, Emanuela Marcelli, Laura Cercenelli, Chiara Mascoli, Cercenelli L., Lodi S., Bortolani B., Mascoli C., Gargiulo M., and Marcelli E.
- Subjects
medicine.medical_specialty ,Software tool ,medicine.medical_treatment ,macromolecular substances ,embolization ,030204 cardiovascular system & hematology ,lcsh:Technology ,Endovascular aneurysm repair ,3D modeling ,lcsh:Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Software ,Aneurysm ,medicine ,EVAR ,General Materials Science ,cardiovascular diseases ,Volume reconstruction ,Embolization ,lcsh:QH301-705.5 ,image segmentation ,Instrumentation ,Fluid Flow and Transfer Processes ,Preoperative planning ,lcsh:T ,business.industry ,Process Chemistry and Technology ,General Engineering ,medicine.disease ,lcsh:QC1-999 ,Abdominal aortic aneurysm ,Computer Science Applications ,preoperative planning ,lcsh:Biology (General) ,lcsh:QD1-999 ,lcsh:TA1-2040 ,aneurysm ,cardiovascular system ,Radiology ,lcsh:Engineering (General). Civil engineering (General) ,business ,lcsh:Physics ,030217 neurology & neurosurgery - Abstract
Background: Endovascular aneurysm repair (EVAR) has become the primary choice of treatment for abdominal aortic aneurysm (AAA) and preventive intraoperative AAA sac embolization (SE) is an effective way to reduce endoleaks after EVAR. Preoperative planning of AAA SE has not been standardized yet, and typically requires a quite long and operator-dependent procedure using standard EVAR planning software. Methods: We introduce &lsquo, EVAR-eaSE&rsquo, a software tool that we have developed to help vascular surgeons to plan the optimal SE procedure during EVAR, providing semi-automatic AAA segmentation and 3D modeling starting from patient scans, and then computing the aneurysm volumes. A preliminary accuracy evaluation on radiological phantoms, and a comparison with the commercial 3Mensio software for EVAR planning are carried out. Results: EVAR-eaSE software showed a good level of accuracy in aneurysm volume reconstruction and calculation (mean difference of 2.5% between real and segmented phantom volumes). A strong positive correlation (r = 0.940, r = 0.954, p <, 0.001) was found between EVAR-eaSE computation of AAA Lumen and AAA Total volumes and the same measurements obtained with 3Mensio, for a database of 26 AAA cases. Conclusions: EVAR-eaSE demonstrated to be an easy-to-use, objective and accurate tool to assist the vascular surgeons in preoperative planning of SE during EVAR.
- Published
- 2020
144. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
- Author
-
Monge, S., Mocroft, A., Sabin, A., Touloumi, G., Sighem, A., Abgrall, S., Dray-Spira, R., Spire, B., Castagna, A., Mussini, C., Zangerle, R., Hessamfar, M., Anderson, J., Hamouda, O., Ehren, K., Obel, N., Kirk, O., Antinori, A., Girardi, E., Saracino, A., Calmy, A., Wit, S., Wittkop, L., Bucher, C., Montoliu, A., Raben, D., Prins, M., Meyer, L., Chene, G., Burns, F., Amo, J., Judd, Ali, Zangerle, Robert, Touloumi, Giota, Warszawski, Josiane, Meyer, Laurence, Dabis, François, Krause, Murielle, Ghosn, Jade, Leport, Catherine, Wittkop, Linda, Reiss, Peter, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Fätkenheuer, Gerd, Amo, Julia, Obel, Niels, Thorne, Claire, Mocroft, Amanda, Kirk, Ole, Stephan, Christoph, Pérez-Hoyos, Santiago, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Noguera-Julian, Antoni, Antinori, Andrea, Monforte, Antonella, Brockmeyer, Norbert, Prieto, Luis, Conejo, Pablo, Soriano-Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Mussini, Cristina, Tookey, Pat, Casabona, Jordi, Miró, Josem, Castagna, Antonella, Konopnick, Deborah, Goetghebuer, Tessa, Sönnerborg, Anders, Torti, Carlo, Sabin, Caroline, Teira, Ramon, Garrido, Myriam, Haerry, David, Wit, Stéphane, Miró, M., Costagliola, Dominique, d'Arminio-Monforte, Antonella, Raben, Dorthe, Chêne, Geneviève, Barger, Diana, Schwimmer, Christine, Termote, Monique, Campbell, Maria, Frederiksen, Casper M, Friis-Møller, Nina, Kjaer, Jesper, Brandt, Rikke, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Cozzi-Lepri, Alessandro, Davies, Mary-Anne, Dorrucci, Maria, Dunn, David, Egger, Matthias, Furrer, Hansjakob, Guiguet, Marguerite, Grabar, Sophie, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Miró, Jose, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Phillips, Andrew, Puoti, Massimo, Rohner, Eliane, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, Valk, Marc, Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in, Eurocoord, Castagna, Antonella, AII - Infectious diseases, APH - Global Health, Infectious diseases, APH - Aging & Later Life, Global Health, Monge, S, Mocroft, A, Sabin, A, Touloumi, G, Sighem, A, Abgrall, S, Dray-Spira, R, Spire, B, Castagna, A, Mussini, C, Zangerle, R, Hessamfar, M, Anderson, J, Hamouda, O, Ehren, K, Obel, N, Kirk, O, Antinori, A, Girardi, E, Saracino, A, Calmy, A, Wit, S, Wittkop, L, Bucher, C, Montoliu, A, Raben, D, Prins, M, Meyer, L, Chene, G, Burns, F, Amo, J, Judd, A, Warszawski, J, Dabis, F, Krause, M, Ghosn, J, Leport, C, Reiss, P, Wit, F, Bucher, H, Gibb, D, Fatkenheuer, G, Thorne, C, Stephan, C, Perez-Hoyos, S, Bartmeyer, B, Chkhartishvili, N, Noguera-Julian, A, Monforte, A, Brockmeyer, N, Prieto, L, Conejo, P, Soriano-Arandes, A, Battegay, M, Kouyos, R, Tookey, P, Casabona, J, Miro, J, Konopnick, D, Goetghebuer, T, Sonnerborg, A, Torti, C, Sabin, C, Teira, R, Garrido, M, Haerry, D, Miro, M, Costagliola, D, d'Arminio-Monforte, A, Barger, D, Schwimmer, C, Termote, M, Campbell, M, Frederiksen, C, Friis-Moller, N, Kjaer, J, Brandt, R, Berenguer, J, Bohlius, J, Bouteloup, V, Cozzi-Lepri, A, Davies, M, Dorrucci, M, Dunn, D, Egger, M, Furrer, H, Guiguet, M, Grabar, S, Lambotte, O, Leroy, V, Lodi, S, Matheron, S, Nakagawa, F, Paredes, R, Phillips, A, Puoti, M, Rohner, E, Schomaker, M, Smit, C, Sterne, J, Thiebaut, R, and Valk, M
- Subjects
Male ,0301 basic medicine ,Latin Americans ,HIV Infections ,migrants ,Anti-Retroviral Agents/therapeutic use ,Cohort Studies ,0302 clinical medicine ,Antiretroviral Therapy, Highly Active ,Epidemiology ,Pharmacology (medical) ,030212 general & internal medicine ,Immunovirological response ,Young adult ,ddc:616 ,Transients and Migrants ,Health Policy ,virus diseases ,Middle Aged ,Viral Load ,3. Good health ,Europe ,combination antiretroviral therapy ,HIV ,immunovirological response ,sex ,Infectious Diseases ,Treatment Outcome ,Anti-Retroviral Agents ,RNA, Viral ,Female ,Sex ,Viral load ,Cohort study ,Adult ,Cart ,Combination antiretroviral therapy ,medicine.medical_specialty ,Adolescent ,HIV Infections/drug therapy ,Young Adult ,03 medical and health sciences ,Population Groups ,medicine ,Humans ,RNA, Viral/blood ,Aged ,business.industry ,Migrant ,030112 virology ,Confidence interval ,CD4 Lymphocyte Count ,migrant ,Institutional repository ,Immunology ,business ,Demography - Abstract
Objectives: The aim of the study was to evaluate differences in immunovirological response to combination antiretroviral therapy (cART) in migrant and native men and women within a European collaboration of HIV cohorts Collaboration of Observational HIV Epidemiological Research in Europ (COHERE) in EuroCoord, 2004-2013. Methods: Migrants were defined as those with geographical origin (GO) different from the reporting country and were grouped as originating from Western Europe and Western Countries (WEWC), Eastern Europe (EE), North Africa and the Middle East (NAME), sub-Saharan Africa (SSA), Latin America (LA), Caribbean (CRB) and Asia/Oceania (ASIA/OCE). Native (NAT) individuals were defined as those originating from the reporting country. CD4 cell counts were modelled using piecewise linear mixed-effects models with two slopes, whereas models to estimate subdistribution hazard ratios (sHRs) were used for time to virological response (VR) (i.e. time from cART initiation to the first of two successive HIV RNA measurements < 400 HIV-1 RNA copies/ml). Results: Of 32 817 individuals, 25 799 (78.6%) were men. The percentage of migrants was higher in women (48.9%) than in men (21.2%) and migrants from SSA accounted for the largest migrant group (29.9% in men and 63.3% in women). Migrant men and women from SSA started at lower CD4 cell counts than NAT individuals, which remained lower over time. VR was ⥠85% at 12 months for all groups except CRB women (77.7%). Compared with NAT men and women, lower VR was experienced by NAME [sHR 0.91; 95% confidence interval (CI) 0.86-0.97] and SSA (sHR 0.88; 95% CI 0.82-0.95) men and CRB (sHR 0.77; 85% CI 0.67-0.89) women, respectively. Conclusions: Immunovirological response to cART in Western Europe varies by GO and sex of patients. ART benefits are not equal for all, underlining the point that efforts need to prioritize those most in need.
- Published
- 2018
145. Medical Emergency Team: valutazione dell’appropriatezza dell’attività intraospedaliera
- Author
-
S. Marangoni, N. M. Bruno, G. D’Alessandro, G. Fumagalli, M. Gaiotto, E. Gandola, S. Lodi, L. I. Mura, E. U. Pelucchi, P. Zappa, E. Beck, M. Saini, G. Citerio, Marangoni, S, Bruno, N, D’Alessandro, G, Fumagalli, G, Gaiotto, M, Gandola, E, Lodi, S, Mura, L, Pelucchi, E, Zappa, P, Beck, E, Saini, M, and Citerio, G
- Subjects
Medical emergency team - Published
- 2018
146. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study
- Author
-
Wittkop, Linda, Arsandaux, Julie, Trevino, Ana, van der Loeff, Maarten Schim, Anderson, Jane, van Sighem, Ard, Böni, Jürg, Brun-Vezinet, Françoise, Soriano, Vicente, Boufassa, Faroudy, Brockmeyer, Norbert, Calmy, Alexandra, Dabis, François, Jarrin, Inma, Dorrucci, Maria, Duque, Vitor, Fätkenheuer, Gerd, Zangerle, Robert, Ferrer, Elena, Porter, Kholoud, Judd, Ali, Sipsas, Nikolaos V., Lambotte, Olivier, Shepherd, Leah, Leport, Catherine, Morrison, Charles, Mussini, Cristina, Obel, Niels, Ruelle, Jean, Schwarze-Zander, Carolyne, Sonnerborg, Anders, Teira, Ramon, Torti, Carlo, Valadas, Emilia, Colin, Celine, Friis-Møller, Nina, Costagliola, Dominique, Thiebaut, Rodolphe, Chene, Geneviève, Matheron, Sophie, Touloumi, Giota, Warszawski, Josiane, Meyer, Laurence, Krause, Murielle Mary, Ghosn, Jade, Reiss, Peter, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Del Amo, Julia, Thorne, Claire, Mocroft, Amanda, Kirk, Ole, Stephan, Christoph, Pérez-Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Noguera-Julian, Antoni, Antinori, Andrea, Monforte, Antonella d'Arminio, Prieto, Luis, Conejo, Pablo Rojo, Soriano-Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Tookey, Pat, Casabona, Jordi, Mirò, Jose M., Castagna, Antonella, Konopnick, Deborah, Goetghebuer, Tessa, Sönnerborg, Anders, Sabin, Caroline, Garrido, Myriam, Haerry, David, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Cozzi-Lepri, Alessandro, Davies, Mary-Anne, Amo, Julia del, Dunn, David, Egger, Matthias, Furrer, Hansjakob, Guiguet, Marguerite, Grabar, Sophie, Leroy, Valériane, Lodi, Sara, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Phillips, Andrew, Puoti, Massimo, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, van der Valk, Marc, Wyss, Natasha, Epidémiologie et Biostatistique, Institut National de la Santé et de la Recherche Médicale (INSERM), Team MORPH3EUS (INSERM U1219 - UB - ISPED), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Infectious Diseases, Hospital Carlos III, Center for Infection and Immunity Amsterdam - CINIMA [Amsterdam, The Netherlands], Homerton University Hospital, Stichting HIV Monitoring [Amsterdam], Universiteit van Amsterdam (UvA), Universität Zürich [Zürich] = University of Zurich (UZH), Université Paris Diderot - Paris 7 (UPD7), Service de Virologie [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Ruhr-Universität Bochum [Bochum], Geneva University Hospital (HUG), CHU de Bordeaux Pellegrin [Bordeaux], Instituto de Salud Carlos III [Madrid] (ISC), CIBER de Epidemiología y Salud Pública (CIBERESP), Istituto Superiore di Sanità (ISS), Hospitais da Universidade de Coimbra (H.U.C.), University of Coimbra [Portugal] (UC), University Hospital of Cologne [Cologne], Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Hospitalet de Llobregat, University College of London [London] (UCL), National and Kapodistrian University of Athens (NKUA), Service de Médecine Interne et Immunologie clinique [AP-HP Hôpital Bicêtre], Hôpital Bicêtre, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), FHI 360, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Rigshospitalet [Copenhagen], Copenhagen University Hospital, Université Catholique de Louvain = Catholic University of Louvain (UCL), University Hospital Bonn, Department of Infectious Diseases, Institution of Medicine, Karolinska University Hospital and Karolinska Institutet, Sierrallana Hospital, Università degli Studi 'Magna Graecia' di Catanzaro = University of Catanzaro (UMG), Universidade de Lisboa = University of Lisbon (ULISBOA), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux [Bordeaux], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Infectious diseases, Wittkop, L, Arsandaux, J, Trevino, A, van der Loeff, M, Anderson, J, van Sighem, A, Böni, J, Brun-Vezinet, F, Soriano, V, Boufassa, F, Brockmeyer, N, Calmy, A, Dabis, F, Jarrin, I, Dorrucci, M, Duque, V, Fätkenheuer, G, Zangerle, R, Ferrer, E, Porter, K, Judd, A, Sipsas, N, Lambotte, O, Shepherd, L, Leport, C, Morrison, C, Mussini, C, Obel, N, Ruelle, J, Schwarze-Zander, C, Sonnerborg, A, Teira, R, Torti, C, Valadas, E, Colin, C, Friis-Møller, N, Costagliola, D, Thiebaut, R, Chene, G, Matheron, S, Touloumi, G, Warszawski, J, Meyer, L, Krause, M, Ghosn, J, Reiss, P, Wit, F, Prins, M, Bucher, H, Gibb, D, Del Amo, J, Thorne, C, Mocroft, A, Kirk, O, Stephan, C, Pérez-Hoyos, S, Hamouda, O, Bartmeyer, B, Chkhartishvili, N, Noguera-Julian, A, Antinori, A, Monforte, A, Prieto, L, Conejo, P, Soriano-Arandes, A, Battegay, M, Kouyos, R, Tookey, P, Casabona, J, Mirò, J, Castagna, A, Konopnick, D, Goetghebuer, T, Sönnerborg, A, Sabin, C, Garrido, M, Haerry, D, Berenguer, J, Bohlius, J, Bouteloup, V, Cozzi-Lepri, A, Davies, M, Amo, J, Dunn, D, Egger, M, Furrer, H, Guiguet, M, Grabar, S, Leroy, V, Lodi, S, Monge, S, Nakagawa, F, Paredes, R, Phillips, A, Puoti, M, Schomaker, M, Smit, C, Sterne, J, van der Valk, M, Wyss, N, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Istituto Superiore di Sanita [Rome], Gestionnaire, Hal Sorbonne Université, Wittkop, Linda, Arsandaux, Julie, Trevino, Ana, Van Der Loeff V Schim, Maarten, Anderson, Jane, Van Sighem, Ard, Jurg, Boni, Brun-Vezinet, Francoise, Soriano, Vicente, Boufassa, Faroudy, Brockmeyer, Norbert, Calmy, Alexandra, Dabis, Francoi, Jarrin, Inma, Dorrucci, Maria, Duque, Vitor, Fãtkenheuer, Gerd, Zangerle, Robert, Ferrer, Elena, Porter, Kholoud, Judd, Ali, Sipsas, Nikolaos V, Lambotte, Olivier, Shepherd, Leah, Leport, Catherine, Morrison, Charle, Mussini, Cristina, Obel, Niel, Ruelle, Jean, Schwarze-Zander, Carolyne, Sonnerborg, Ander, Teira, Ramon, Torti, Carlo, Valadas, Emilia, Colin, Celine, Friis-Moller, Nina, Costagliola, Dominique, Thiebaut, Rodolphe, Chene, Geneviève, Matheron, Sophie, on behalf of the COHERE in EuroCoord and ACHIeV2e Study, Group, and Castagna, Antonella
- Subjects
0301 basic medicine ,CD4-Positive T-Lymphocytes ,Male ,Internationality ,[SDV]Life Sciences [q-bio] ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Gastroenterology ,Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use ,Viral/blood ,Cohort Studies ,0302 clinical medicine ,CD4 HIV ,Pharmacology (medical) ,030212 general & internal medicine ,Cd4 cell count ,ddc:616 ,Confounding ,virus diseases ,Middle Aged ,Viral Load ,3. Good health ,[SDV] Life Sciences [q-bio] ,Europe ,HIV-2/drug effects ,Infectious Diseases ,HIV-1/drug effects ,RNA, Viral ,Female ,Viral load ,Cohort study ,Microbiology (medical) ,Cart ,Adult ,medicine.medical_specialty ,Anti-HIV Agents ,030106 microbiology ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Pharmacology ,business.industry ,CD4-Positive T-Lymphocytes/immunology/virology ,CD4 Lymphocyte Count ,Institutional repository ,HIV Infections/blood/drug therapy/immunology/virology ,HIV-2 ,HIV-1 ,RNA ,Panton–Valentine leukocidin ,business - Abstract
Background: CD4 cell recovery following first-line combination ART (cART) is poorer in HIV-2+ than in HIV-1+ patients. Only large comparisons may allow adjustments for demographic and pretreatment plasma viral load (pVL). Methods: ART-naive HIV+ adults from two European multicohort collaborations, COHERE (HIV-1 alone) and ACHIeV2e (HIV-2 alone), were included, if they started first-line cART (without NNRTIs or fusion inhibitors) between 1997 and 2011. Patients without at least one CD4 cell count before start of cART, without a pretreatment pVL and with missing a priori-defined covariables were excluded. Evolution of CD4 cell count was studied using adjusted linear mixed models. Results: We included 185 HIV-2+ and 30321 HIV-1+ patients with median age of 46 years (IQR 36-52) and 37 years (IQR 31-44), respectively. Median observed pretreatment CD4 cell counts/mm(3) were 203 (95% CI 100-290) in HIV-2+ patients and 223 (95% CI 100-353) in HIV-1+ patients. Mean observed CD4 cell count changes from start of cART to 12months were + 105 (95% CI 77-134) in HIV-2+ patients and + 202 (95% CI 199-205) in HIV-1+ patients, an observed difference of 97 cells/mm(3) in 1 year. In adjusted analysis, the mean CD4 cell increase was overall 25 CD4 cells/mm(3)/year lower (95% CI 5-44; P=0.0127) in HIV-2+ patients compared with HIV-1+ patients. Conclusions: A poorer CD4 cell increase during first-line cART was observed in HIV-2+ patients, even after adjusting for pretreatment pVL and other potential confounders. Our results underline the need to identify more potent therapeutic regimens or strategies against HIV-2
- Published
- 2017
147. VidaMine: A visual data mining environment
- Author
-
Claudio Sartori, Stefano Lodi, Giuseppe Santucci, Tiziana Catarci, Stephen Kimani, LODI S, CATARCI T, SANTUCCI G, and SARTORI C.
- Subjects
visual interface ,Syntax (programming languages) ,Data stream mining ,Computer science ,Process (engineering) ,VISUALI INTERFACE ,data mining ,computer.software_genre ,Data science ,Language and Linguistics ,Computer Science Applications ,usability ,Human-Computer Interaction ,Business process discovery ,Knowledge extraction ,Component (UML) ,Data mining ,Open architecture ,computer ,Data integration - Abstract
That the already vast and ever-increasing amounts of data still do present formidable challenges to effective and efficient acquisition of knowledge is by no means an exaggeration. The knowledge discovery process entails more than just the application of data mining strategies. There are many other aspects including, but not limited to: planning, data pre-processing, data integration, evaluation and presentation. The human-vision channel is capable of recognizing and understanding data at an instant. Effective visual strategies can be used to tap the outstanding human visual channel in extracting useful information from data. Unlike is the case with most research efforts, the exploitation should be employed not just at the beginning or at the end of the knowledge discovery process but across the entire discovery process. In essence, this calls for the development of an effective user/visual component, the development of an overall framework that can support the entire discovery process/all discovery phases, and the strategic placement of the visual component in that framework. Key issues of this component will be the open architecture, allowing extensions and adaptations to specific mining environments, and the precise semantics and syntax, allowing an optimal integration between the presentation and the computation.
- Published
- 2004
148. Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder.
- Author
-
Biondi BE, Munroe S, Lavarin C, Curtis MR, Buzzee B, Lodi S, and Epstein RL
- Abstract
Background: In the United States, hepatitis C virus (HCV) diagnoses among reproductive-aged women are increasing amidst the ongoing opioid and drug overdose epidemic. While previous studies document racial and ethnic disparities in HCV testing and treatment in largely male populations, to our knowledge no national studies analyze these outcomes in reproductive-aged women with opioid use disorder (OUD)., Methods: We analyzed data from a cohort of reproductive-aged women (aged 15-44 years) with diagnosed OUD captured in the TriNetX Research Network, a network of electronic health records from across the United States. Using a log-binomial model, we assessed differences in achieving HCV cascade of care stages (HCV antibody testing, HCV infection [positive HCV RNA test result], linkage to care, and HCV treatment) by race and ethnicity., Results: From 2014 to 2022, 44.6% of the cohort were tested for HCV antibody. Asian and black/African American individuals had a lower probability of having an HCV antibody test than white individuals (risk ratio, 0.77 [95% confidence interval, .62-.96] and 0.76 [.63-.92], respectively). Among those with HCV infection, only 9.1% were treated with direct-acting antivirals. Hispanic/Latinx individuals had a higher probability of treatment than non-Hispanic/Latinx individuals (risk ratio, 1.63 [95% confidence interval, 1.01-2.61])., Conclusions: Few reproductive-aged women with OUD are tested or treated for HCV. Disparities by race and ethnicity in HCV testing further exacerbate the risk of perinatal transmission and disease progression among minoritized communities. Interventions are needed to improve overall rates of and equity in HCV screening and treatment for reproductive-aged women., Competing Interests: Potential conflicts of interest . The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
149. The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment.
- Author
-
Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, and Saitz R
- Abstract
Objectives: The COVID-19 pandemic led to increased substance-related morbidity and mortality and transformed care for opioid use disorder (OUD). We assessed the perceived impacts of the pandemic on substance use and related consequences among patients in office-based addiction treatment (OBAT)., Methods: We recruited patients with OUD on buprenorphine from July 2021 to July 2022, with data collection at baseline and 6 months. Exposures of interest were the following 6 domains potentially impacted by COVID-19: personal or family infection, difficulty accessing healthcare/medication, economic stressors, worsening physical or mental health, social isolation, and conflicts/disruptions in the home. Outcomes were past 30-day alcohol and other substance use, increased use, and substance-related consequences at baseline and 6 months. Generalized estimating equations Poisson regression models quantified associations between increasing impact domain scores and relative risks of each outcome., Results: All participants (N = 150) reported at least one domain negatively impacted by COVID-19 at both time points. Higher "worsening physical or mental health" domain scores were associated with increased relative risk of recent alcohol or drug use (adjusted risk ratio [aRR] 1.04, 95% confidence interval [CI]: 1.01-1.07). Relative risks of experiencing substance-related consequences increased with higher scores in the domains of economic stressors (aRR 1.07, 95% CI: 1.02-1.13), difficulty accessing healthcare/medication (aRR 1.11, 95% CI: 1.04-1.19), and worsening physical or mental health (aRR 1.08, 95% CI: 1.04-1.12)., Conclusions: Among patients with OUD, stressors from COVID-19 were common. Three life domains impacted by COVID-19 appeared to be associated with consequential substance use, highlighting opportunities to address barriers to healthcare access and economic stressors., Competing Interests: The authors report no conflicts of interest., (Copyright © 2024 American Society of Addiction Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
150. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia.
- Author
-
Idrisov B, Van Draanen J, Lodi S, Lunze K, Kimmel SD, Quinn EK, Truong V, Blokhina E, Gnatienko N, Krupitsky E, Samet JH, and Williams EC
- Subjects
- Humans, Male, Female, Russia epidemiology, Adult, CD4 Lymphocyte Count, Middle Aged, Socioeconomic Factors, Health Services Accessibility, HIV Infections drug therapy, HIV Infections epidemiology, Substance Abuse, Intravenous epidemiology, Substance Abuse, Intravenous complications, Social Class
- Abstract
Lack of access to resources is a "fundamental cause" of poor HIV outcomes across the care cascade globally and may have the greatest impact on groups with co-existing marginalized identities. In a sample of people living with HIV (PWH) who inject drugs and were not on antiretroviral therapy (ART), we explored associations between access to resources and HIV severity. Fundamental Cause Theory (FCT) sees socioeconomic status/access to resources as a root cause of disease and emphasizes that individuals with limited resources have fewer means to mitigate health risks and implement protective behaviors, which ultimately generates disparities in health outcomes. Guided by the FCT, we hypothesized that resource depletion (primary aim) and lower income (secondary aim) were associated with increased HIV severity. Using baseline data from the Linking Infectious and Narcology Care (LINC-II) trial of ART-naive PWH who inject drugs in St. Petersburg, Russia (n = 225), we examined the association between "past year resource runout" (yes vs. no) and "low-income (< 300 USD a month)" and the outcome HIV severity (CD4 count, continuous). We fit two separate linear regression models adjusted for gender, age, time since HIV diagnosis, and prior ART use. Participants had a mean age of 37.5 years and were 60% male. Two thirds (66%) reported resource depletion, and 30% had income below 300 USD a month. Average CD4 count was 416 cells/mm
3 (SD 285). No significant association was identified between either resource depletion or low-income and HIV severity (adjusted mean difference in CD4 count for resource depletion: - 4.16, 95% CI - 82.93, 74.62; adjusted mean difference in CD4 count for low-income: 68.13, 95% CI - 15.78, 152.04). Below-average income and running out of resources were common among PWH who inject drugs and are not on ART in St. Petersburg, Russia. Resource depletion and low-income were not significantly associated with HIV disease severity as captured by CD4 count. The nuanced relationship between socioeconomic status and HIV severity among people with HIV who inject drugs and not on ART merits further examination in a larger sample., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.